Literature DB >> 6165830

Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

S Goff, P Traktman, D Baltimore.   

Abstract

A rapid assay for retroviral reverse transcriptase activity released into the culture medium by infected cells was developed. With the assay, 4,000 clonally infected cell lines could be tested in a few hours. We have adapted the assay for use as a screen for the detection of spontaneous viral mutants. Mutants of Moloney murine leukemia virus have been isolated which (i) produce a thermolabile reverse transcriptase, (ii) are temperature sensitive for release of enzyme activity, or (iii) can only productively infect cells already producing gag-related polypeptides. The assay has also been useful for the isolation of nonproducer cells infected with various replication-defective transforming viruses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165830      PMCID: PMC171145          DOI: 10.1128/JVI.38.1.239-248.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Defective cleavage of a precursor polypeptide in a temperature-sensitive mutant of avian sarcoma virus.

Authors:  J M Rohrschneider; H Diggelmann; H Ogura; R R Friis; H Bauer
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

2.  Characterization of two conditional early mutants of Rous sarcoma virus.

Authors:  M Linial; W S Mason
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

3.  Characterization of temperature-sensitive mutants of murine leukemia virus.

Authors:  J R Stephenson; S A Aaronson
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

4.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

5.  A mutant of Rous sarcoma virus with a conditional defect in the determinant(s) of viral host range.

Authors:  W S Mason; C Yeater
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Endogenous ecotropic mouse type C viruses deficient in replication and production of XC plaques.

Authors:  U R Rapp; R C Nowinski
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

8.  Variants of N-tropic leukemia virus derived from BALB/c mice.

Authors:  N Hopkins; P Jolicoeur
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

9.  Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.

Authors:  S R Tronick; J R Stephenson; I M Verma; S A Aaronson
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

10.  A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization.

Authors:  A L Rein; B I Gerwin; R H Bassin; L Schwarm; G Schidlovsky
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

View more
  233 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Interaction of Moloney murine leukemia virus matrix protein with IQGAP.

Authors:  Juliana Leung; Andrew Yueh; Frank S K Appah; Bing Yuan; Kenia de los Santos; Stephen P Goff
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

3.  Lipid rafts and pseudotyping.

Authors:  W F Pickl; F X Pimentel-Muiños; B Seed
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.

Authors:  A Telesnitsky; S W Blain; S P Goff
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes.

Authors:  Y Takahara; K Hamada; D E Housman
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.

Authors:  M J Roth; P Schwartzberg; N Tanese; S P Goff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.

Authors:  K A Qatsha; C Rudolph; D Marmé; C Schächtele; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.